ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Morphine Sulfate Extended Release Tablets Market Research Report 2026
Published Date: 2026-03-11
|
Report Code: QYRE-Auto-2Z18035
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Morphine Sulfate Extended Release Tablets Market Research Report 2024
BUY CHAPTERS

Global Morphine Sulfate Extended Release Tablets Market Research Report 2026

Code: QYRE-Auto-2Z18035
Report
2026-03-11
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Viatris
Allergan plc
Rhodes Pharmaceuticals
West Ward Pharmaceuticals

Morphine Sulfate Extended Release Tablets Market

The global Morphine Sulfate Extended Release Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Morphine Sulfate Extended Release Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Morphine Sulfate Extended Release Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Morphine Sulfate Extended Release Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Morphine Sulfate Extended Release Tablets include NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Morphine Sulfate Extended Release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Morphine Sulfate Extended Release Tablets. The Morphine Sulfate Extended Release Tablets market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Morphine Sulfate Extended Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Morphine Sulfate Extended Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Morphine Sulfate Extended Release Tablets Market Report

Report Metric Details
Report Name Morphine Sulfate Extended Release Tablets Market
Segment by Type
  • 10mg
  • 30mg
  • 60mg
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Morphine Sulfate Extended Release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Morphine Sulfate Extended Release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Morphine Sulfate Extended Release Tablets Market report?

Ans: The main players in the Morphine Sulfate Extended Release Tablets Market are NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, Allergan, Rhodes Pharmaceuticals, West-Ward Pharmaceuticals

What are the Application segmentation covered in the Morphine Sulfate Extended Release Tablets Market report?

Ans: The Applications covered in the Morphine Sulfate Extended Release Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Morphine Sulfate Extended Release Tablets Market report?

Ans: The Types covered in the Morphine Sulfate Extended Release Tablets Market report are 10mg, 30mg, 60mg

1 Morphine Sulfate Extended Release Tablets Market Overview
1.1 Product Definition
1.2 Morphine Sulfate Extended Release Tablets by Type
1.2.1 Global Morphine Sulfate Extended Release Tablets Market Value by Type: 2025 vs 2032
1.2.2 10mg
1.2.3 30mg
1.2.4 60mg
1.3 Morphine Sulfate Extended Release Tablets by Application
1.3.1 Global Morphine Sulfate Extended Release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Morphine Sulfate Extended Release Tablets Market Size Estimates and Forecasts
1.4.1 Global Morphine Sulfate Extended Release Tablets Revenue 2021–2032
1.4.2 Global Morphine Sulfate Extended Release Tablets Sales 2021–2032
1.4.3 Global Morphine Sulfate Extended Release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Morphine Sulfate Extended Release Tablets Market Competition by Manufacturers
2.1 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Morphine Sulfate Extended Release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Morphine Sulfate Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Date of Entry into the Industry
2.8 Global Morphine Sulfate Extended Release Tablets Market Competitive Situation and Trends
2.8.1 Global Morphine Sulfate Extended Release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Morphine Sulfate Extended Release Tablets Players Market Share by Revenue
2.8.3 Global Morphine Sulfate Extended Release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Morphine Sulfate Extended Release Tablets Market Scenario by Region
3.1 Global Morphine Sulfate Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Morphine Sulfate Extended Release Tablets Sales by Region: 2021–2032
3.2.1 Global Morphine Sulfate Extended Release Tablets Sales by Region: 2021–2026
3.2.2 Global Morphine Sulfate Extended Release Tablets Sales by Region: 2027–2032
3.3 Global Morphine Sulfate Extended Release Tablets Revenue by Region: 2021–2032
3.3.1 Global Morphine Sulfate Extended Release Tablets Revenue by Region: 2021–2026
3.3.2 Global Morphine Sulfate Extended Release Tablets Revenue by Region: 2027–2032
3.4 North America Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.4.1 North America Morphine Sulfate Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Morphine Sulfate Extended Release Tablets Sales by Country (2021–2032)
3.4.3 North America Morphine Sulfate Extended Release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.5.1 Europe Morphine Sulfate Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Morphine Sulfate Extended Release Tablets Sales by Country (2021–2032)
3.5.3 Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Morphine Sulfate Extended Release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Morphine Sulfate Extended Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Morphine Sulfate Extended Release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.7.1 Latin America Morphine Sulfate Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Morphine Sulfate Extended Release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Morphine Sulfate Extended Release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Morphine Sulfate Extended Release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Morphine Sulfate Extended Release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Morphine Sulfate Extended Release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Morphine Sulfate Extended Release Tablets Sales by Type (2021–2032)
4.1.1 Global Morphine Sulfate Extended Release Tablets Sales by Type (2021–2026)
4.1.2 Global Morphine Sulfate Extended Release Tablets Sales by Type (2027–2032)
4.1.3 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Morphine Sulfate Extended Release Tablets Revenue by Type (2021–2032)
4.2.1 Global Morphine Sulfate Extended Release Tablets Revenue by Type (2021–2026)
4.2.2 Global Morphine Sulfate Extended Release Tablets Revenue by Type (2027–2032)
4.2.3 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Morphine Sulfate Extended Release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Morphine Sulfate Extended Release Tablets Sales by Application (2021–2032)
5.1.1 Global Morphine Sulfate Extended Release Tablets Sales by Application (2021–2026)
5.1.2 Global Morphine Sulfate Extended Release Tablets Sales by Application (2027–2032)
5.1.3 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Morphine Sulfate Extended Release Tablets Revenue by Application (2021–2032)
5.2.1 Global Morphine Sulfate Extended Release Tablets Revenue by Application (2021–2026)
5.2.2 Global Morphine Sulfate Extended Release Tablets Revenue by Application (2027–2032)
5.2.3 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Morphine Sulfate Extended Release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 NAPP PHARMACEUTICALS LIMITED
6.1.1 NAPP PHARMACEUTICALS LIMITED Company Information
6.1.2 NAPP PHARMACEUTICALS LIMITED Description and Business Overview
6.1.3 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product Portfolio
6.1.5 NAPP PHARMACEUTICALS LIMITED Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Company Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Purdue Pharma Morphine Sulfate Extended Release Tablets Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt Pharmaceuticals
6.3.1 Mallinckrodt Pharmaceuticals Company Information
6.3.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.3.3 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.3.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Company Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Viatris Morphine Sulfate Extended Release Tablets Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Company Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Allergan Morphine Sulfate Extended Release Tablets Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 Rhodes Pharmaceuticals
6.7.1 Rhodes Pharmaceuticals Company Information
6.7.2 Rhodes Pharmaceuticals Description and Business Overview
6.7.3 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.7.5 Rhodes Pharmaceuticals Recent Developments/Updates
6.8 West-Ward Pharmaceuticals
6.8.1 West-Ward Pharmaceuticals Company Information
6.8.2 West-Ward Pharmaceuticals Description and Business Overview
6.8.3 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolio
6.8.5 West-Ward Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Morphine Sulfate Extended Release Tablets Industry Chain Analysis
7.2 Morphine Sulfate Extended Release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Morphine Sulfate Extended Release Tablets Production Mode & Process Analysis
7.4 Morphine Sulfate Extended Release Tablets Sales and Marketing
7.4.1 Morphine Sulfate Extended Release Tablets Sales Channels
7.4.2 Morphine Sulfate Extended Release Tablets Distributors
7.5 Morphine Sulfate Extended Release Tablets Customer Analysis
8 Morphine Sulfate Extended Release Tablets Market Dynamics
8.1 Morphine Sulfate Extended Release Tablets Industry Trends
8.2 Morphine Sulfate Extended Release Tablets Market Drivers
8.3 Morphine Sulfate Extended Release Tablets Market Challenges
8.4 Morphine Sulfate Extended Release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Viatris
Allergan plc
Rhodes Pharmaceuticals
West Ward Pharmaceuticals
List of Tables
 Table 1. Global Morphine Sulfate Extended Release Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Morphine Sulfate Extended Release Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Morphine Sulfate Extended Release Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Morphine Sulfate Extended Release Tablets Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Morphine Sulfate Extended Release Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Morphine Sulfate Extended Release Tablets Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Morphine Sulfate Extended Release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Morphine Sulfate Extended Release Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Morphine Sulfate Extended Release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Morphine Sulfate Extended Release Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Morphine Sulfate Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Morphine Sulfate Extended Release Tablets Sales by Region (Tons), 2021–2026
 Table 18. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Morphine Sulfate Extended Release Tablets Sales by Region (Tons), 2027–2032
 Table 20. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Morphine Sulfate Extended Release Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Morphine Sulfate Extended Release Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Morphine Sulfate Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2021–2026
 Table 27. North America Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2027–2032
 Table 28. North America Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Morphine Sulfate Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2021–2026
 Table 32. Europe Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2027–2032
 Table 33. Europe Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Morphine Sulfate Extended Release Tablets Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Morphine Sulfate Extended Release Tablets Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Morphine Sulfate Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2021–2026
 Table 42. Latin America Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2027–2032
 Table 43. Latin America Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Morphine Sulfate Extended Release Tablets Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Type (2021–2026)
 Table 51. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Type (2027–2032)
 Table 52. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Application (2021–2026)
 Table 61. Global Morphine Sulfate Extended Release Tablets Sales (Tons) by Application (2027–2032)
 Table 62. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Morphine Sulfate Extended Release Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Application (2027–2032)
 Table 70. NAPP PHARMACEUTICALS LIMITED Company Information
 Table 71. NAPP PHARMACEUTICALS LIMITED Description and Business Overview
 Table 72. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product
 Table 74. NAPP PHARMACEUTICALS LIMITED Recent Developments/Updates
 Table 75. Purdue Pharma Company Information
 Table 76. Purdue Pharma Description and Business Overview
 Table 77. Purdue Pharma Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. Purdue Pharma Morphine Sulfate Extended Release Tablets Product
 Table 79. Purdue Pharma Recent Developments/Updates
 Table 80. Mallinckrodt Pharmaceuticals Company Information
 Table 81. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 82. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 84. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 85. Teva Pharmaceuticals Company Information
 Table 86. Teva Pharmaceuticals Description and Business Overview
 Table 87. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 89. Teva Pharmaceuticals Recent Developments/Updates
 Table 90. Viatris Company Information
 Table 91. Viatris Description and Business Overview
 Table 92. Viatris Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Viatris Morphine Sulfate Extended Release Tablets Product
 Table 94. Viatris Recent Developments/Updates
 Table 95. Allergan Company Information
 Table 96. Allergan Description and Business Overview
 Table 97. Allergan Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. Allergan Morphine Sulfate Extended Release Tablets Product
 Table 99. Allergan Recent Developments/Updates
 Table 100. Rhodes Pharmaceuticals Company Information
 Table 101. Rhodes Pharmaceuticals Description and Business Overview
 Table 102. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 103. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 104. Rhodes Pharmaceuticals Recent Developments/Updates
 Table 105. West-Ward Pharmaceuticals Company Information
 Table 106. West-Ward Pharmaceuticals Description and Business Overview
 Table 107. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 108. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product
 Table 109. West-Ward Pharmaceuticals Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Morphine Sulfate Extended Release Tablets Distributors List
 Table 113. Morphine Sulfate Extended Release Tablets Customers List
 Table 114. Morphine Sulfate Extended Release Tablets Market Trends
 Table 115. Morphine Sulfate Extended Release Tablets Market Drivers
 Table 116. Morphine Sulfate Extended Release Tablets Market Challenges
 Table 117. Morphine Sulfate Extended Release Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Morphine Sulfate Extended Release Tablets
 Figure 2. Global Morphine Sulfate Extended Release Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Morphine Sulfate Extended Release Tablets Market Share by Type: 2025 & 2032
 Figure 4. 10mg Product Picture
 Figure 5. 30mg Product Picture
 Figure 6. 60mg Product Picture
 Figure 7. Global Morphine Sulfate Extended Release Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Morphine Sulfate Extended Release Tablets Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Morphine Sulfate Extended Release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Morphine Sulfate Extended Release Tablets Market Size (US$ Million), 2021–2032
 Figure 14. Global Morphine Sulfate Extended Release Tablets Sales (Tons), 2021–2032
 Figure 15. Global Morphine Sulfate Extended Release Tablets Average Price (US$/Ton), 2021–2032
 Figure 16. Morphine Sulfate Extended Release Tablets Report Years Considered
 Figure 17. Morphine Sulfate Extended Release Tablets Sales Share by Manufacturers in 2025
 Figure 18. Global Morphine Sulfate Extended Release Tablets Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Morphine Sulfate Extended Release Tablets Players: Market Share by Revenue in Morphine Sulfate Extended Release Tablets in 2025
 Figure 20. Morphine Sulfate Extended Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Morphine Sulfate Extended Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021–2032)
 Figure 23. North America Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021–2032)
 Figure 24. United States Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021–2032)
 Figure 27. Europe Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2021–2032)
 Figure 35. China Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Morphine Sulfate Extended Release Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Morphine Sulfate Extended Release Tablets by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Morphine Sulfate Extended Release Tablets by Type (2021–2032)
 Figure 55. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Morphine Sulfate Extended Release Tablets by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Morphine Sulfate Extended Release Tablets by Application (2021–2032)
 Figure 58. Global Morphine Sulfate Extended Release Tablets Price (US$/Ton) by Application (2021–2032)
 Figure 59. Morphine Sulfate Extended Release Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Morphine Sulfate Injection Market Research Report 2024
Global Morphine Sulfat Market Research Report 2025
Global Doxazosin Mesylate Extended Release Tablets Market Research Report 2024
Global Hydroxychloroquine Sulfate Tablets Market Research Report 2024
Global Glucosamine Sulfate Tablets and Capsules Market Research Report 2024
Global Oxycodone Hydrochloride Extended Release Tablets Market Research Report 2024
Global Magnesium Laureth Sulfate Market Research Report 2025
Global Terbutaline Sulfate Tablets Market Research Report 2024
Global Pharmaceutical Grade Sulphate Market Research Report 2024
Global Glucosamine Sulfate Capsules Market Research Report 2024
Global High Purity Magnesium Sulfate Market Research Report 2024
Global Paromomycin Sulfate Market Research Report 2025
Global Polymyxin B Sulfate Market Research Report 2024
Global Tobramycin Sulfate Injection Market Research Report 2024
Morphine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vindesine Sulfate Market Research Report 2024
Global Vincristine sulfate Market Research Report 2024
Global Alcohol Ether Sulfate Market Research Report 2025
Global Sodium Octyl Sulfate Market Research Report 2025
Paliperidone Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions